The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Immuno-Oncology Market Insights and Forecast to 2028
Synopsis
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
Market Analysis and Insights: Global Immuno-Oncology Market
The global Immuno-Oncology market size is projected to reach US$ 116680 million by 2028, from US$ 43650 million in 2021, at a CAGR of 14.9% during 2022-2028.
The industry's leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immuno-Oncology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immuno-Oncology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immuno-Oncology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immuno-Oncology market.
Global Immuno-Oncology Scope and Market Size
Immuno-Oncology market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Immuno-Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Segment by Application
Hospitals
Drugstores
Others
By Company
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
Market Analysis and Insights: Global Immuno-Oncology Market
The global Immuno-Oncology market size is projected to reach US$ 116680 million by 2028, from US$ 43650 million in 2021, at a CAGR of 14.9% during 2022-2028.
The industry's leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immuno-Oncology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immuno-Oncology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immuno-Oncology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immuno-Oncology market.
Global Immuno-Oncology Scope and Market Size
Immuno-Oncology market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Immuno-Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Segment by Application
Hospitals
Drugstores
Others
By Company
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Index1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Oncology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Immuno-Oncology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Market Perspective (2017-2028)
2.2 Immuno-Oncology Growth Trends by Region
2.2.1 Immuno-Oncology Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immuno-Oncology Historic Market Size by Region (2017-2022)
2.2.3 Immuno-Oncology Forecasted Market Size by Region (2023-2028)
2.3 Immuno-Oncology Market Dynamics
2.3.1 Immuno-Oncology Industry Trends
2.3.2 Immuno-Oncology Market Drivers
2.3.3 Immuno-Oncology Market Challenges
2.3.4 Immuno-Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Players by Revenue
3.1.1 Global Top Immuno-Oncology Players by Revenue (2017-2022)
3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2017-2022)
3.2 Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-Oncology Revenue
3.4 Global Immuno-Oncology Market Concentration Ratio
3.4.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2021
3.5 Immuno-Oncology Key Players Head office and Area Served
3.6 Key Players Immuno-Oncology Product Solution and Service
3.7 Date of Enter into Immuno-Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Oncology Breakdown Data by Type
4.1 Global Immuno-Oncology Historic Market Size by Type (2017-2022)
4.2 Global Immuno-Oncology Forecasted Market Size by Type (2023-2028)
5 Immuno-Oncology Breakdown Data by Application
5.1 Global Immuno-Oncology Historic Market Size by Application (2017-2022)
5.2 Global Immuno-Oncology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immuno-Oncology Market Size (2017-2028)
6.2 North America Immuno-Oncology Market Size by Type
6.2.1 North America Immuno-Oncology Market Size by Type (2017-2022)
6.2.2 North America Immuno-Oncology Market Size by Type (2023-2028)
6.2.3 North America Immuno-Oncology Market Share by Type (2017-2028)
6.3 North America Immuno-Oncology Market Size by Application
6.3.1 North America Immuno-Oncology Market Size by Application (2017-2022)
6.3.2 North America Immuno-Oncology Market Size by Application (2023-2028)
6.3.3 North America Immuno-Oncology Market Share by Application (2017-2028)
6.4 North America Immuno-Oncology Market Size by Country
6.4.1 North America Immuno-Oncology Market Size by Country (2017-2022)
6.4.2 North America Immuno-Oncology Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Immuno-Oncology Market Size (2017-2028)
7.2 Europe Immuno-Oncology Market Size by Type
7.2.1 Europe Immuno-Oncology Market Size by Type (2017-2022)
7.2.2 Europe Immuno-Oncology Market Size by Type (2023-2028)
7.2.3 Europe Immuno-Oncology Market Share by Type (2017-2028)
7.3 Europe Immuno-Oncology Market Size by Application
7.3.1 Europe Immuno-Oncology Market Size by Application (2017-2022)
7.3.2 Europe Immuno-Oncology Market Size by Application (2023-2028)
7.3.3 Europe Immuno-Oncology Market Share by Application (2017-2028)
7.4 Europe Immuno-Oncology Market Size by Country
7.4.1 Europe Immuno-Oncology Market Size by Country (2017-2022)
7.4.2 Europe Immuno-Oncology Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Market Size (2017-2028)
8.2 Asia-Pacific Immuno-Oncology Market Size by Type
8.2.1 Asia-Pacific Immuno-Oncology Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Immuno-Oncology Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Immuno-Oncology Market Share by Type (2017-2028)
8.3 Asia-Pacific Immuno-Oncology Market Size by Application
8.3.1 Asia-Pacific Immuno-Oncology Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Immuno-Oncology Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Immuno-Oncology Market Share by Application (2017-2028)
8.4 Asia-Pacific Immuno-Oncology Market Size by Region
8.4.1 Asia-Pacific Immuno-Oncology Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Immuno-Oncology Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immuno-Oncology Market Size (2017-2028)
9.2 Latin America Immuno-Oncology Market Size by Type
9.2.1 Latin America Immuno-Oncology Market Size by Type (2017-2022)
9.2.2 Latin America Immuno-Oncology Market Size by Type (2023-2028)
9.2.3 Latin America Immuno-Oncology Market Share by Type (2017-2028)
9.3 Latin America Immuno-Oncology Market Size by Application
9.3.1 Latin America Immuno-Oncology Market Size by Application (2017-2022)
9.3.2 Latin America Immuno-Oncology Market Size by Application (2023-2028)
9.3.3 Latin America Immuno-Oncology Market Share by Application (2017-2028)
9.4 Latin America Immuno-Oncology Market Size by Country
9.4.1 Latin America Immuno-Oncology Market Size by Country (2017-2022)
9.4.2 Latin America Immuno-Oncology Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Market Size (2017-2028)
10.2 Middle East & Africa Immuno-Oncology Market Size by Type
10.2.1 Middle East & Africa Immuno-Oncology Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Immuno-Oncology Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Immuno-Oncology Market Share by Type (2017-2028)
10.3 Middle East & Africa Immuno-Oncology Market Size by Application
10.3.1 Middle East & Africa Immuno-Oncology Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Immuno-Oncology Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Immuno-Oncology Market Share by Application (2017-2028)
10.4 Middle East & Africa Immuno-Oncology Market Size by Country
10.4.1 Middle East & Africa Immuno-Oncology Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Immuno-Oncology Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
11.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2017-2022)
11.1.5 Bristol-Myers Squibb Recent Developments
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Details
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
11.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2017-2022)
11.2.5 Merck & Co., Inc. Recent Developments
11.3 Roche AG
11.3.1 Roche AG Company Details
11.3.2 Roche AG Business Overview
11.3.3 Roche AG Immuno-Oncology Introduction
11.3.4 Roche AG Revenue in Immuno-Oncology Business (2017-2022)
11.3.5 Roche AG Recent Developments
11.4 AstraZeneca, Plc
11.4.1 AstraZeneca, Plc Company Details
11.4.2 AstraZeneca, Plc Business Overview
11.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
11.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2017-2022)
11.4.5 AstraZeneca, Plc Recent Developments
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Details
11.5.2 Sanofi S.A. Business Overview
11.5.3 Sanofi S.A. Immuno-Oncology Introduction
11.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2017-2022)
11.5.5 Sanofi S.A. Recent Developments
11.6 Dendreon Pharmaceuticals
11.6.1 Dendreon Pharmaceuticals Company Details
11.6.2 Dendreon Pharmaceuticals Business Overview
11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
11.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2017-2022)
11.6.5 Dendreon Pharmaceuticals Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Immuno-Oncology Introduction
11.7.4 Novartis Revenue in Immuno-Oncology Business (2017-2022)
11.7.5 Novartis Recent Developments
11.8 Gilead Sciences Inc.
11.8.1 Gilead Sciences Inc. Company Details
11.8.2 Gilead Sciences Inc. Business Overview
11.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
11.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2017-2022)
11.8.5 Gilead Sciences Inc. Recent Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Immuno-Oncology Introduction
11.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2017-2022)
11.9.5 Merck KGaA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Immuno-Oncology Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Immune Checkpoint Inhibitors
Table 3. Key Players of Cytokine-Based Immunotherapy
Table 4. Key Players of Cancer Vaccines
Table 5. Key Players of CAR-T Cell Therapy
Table 6. Key Players of Others
Table 7. Global Immuno-Oncology Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Immuno-Oncology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Immuno-Oncology Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Immuno-Oncology Market Share by Region (2017-2022)
Table 11. Global Immuno-Oncology Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Immuno-Oncology Market Share by Region (2023-2028)
Table 13. Immuno-Oncology Market Trends
Table 14. Immuno-Oncology Market Drivers
Table 15. Immuno-Oncology Market Challenges
Table 16. Immuno-Oncology Market Restraints
Table 17. Global Immuno-Oncology Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Immuno-Oncology Revenue Share by Players (2017-2022)
Table 19. Global Top Immuno-Oncology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2021)
Table 20. Ranking of Global Top Immuno-Oncology Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immuno-Oncology Product Solution and Service
Table 24. Date of Enter into Immuno-Oncology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Immuno-Oncology Revenue Market Share by Type (2017-2022)
Table 28. Global Immuno-Oncology Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Immuno-Oncology Revenue Market Share by Type (2023-2028)
Table 30. Global Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Immuno-Oncology Revenue Share by Application (2017-2022)
Table 32. Global Immuno-Oncology Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Immuno-Oncology Revenue Share by Application (2023-2028)
Table 34. North America Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Immuno-Oncology Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Immuno-Oncology Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Immuno-Oncology Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Immuno-Oncology Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Immuno-Oncology Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Immuno-Oncology Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Immuno-Oncology Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Immuno-Oncology Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Immuno-Oncology Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Immuno-Oncology Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Immuno-Oncology Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Immuno-Oncology Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Immuno-Oncology Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Immuno-Oncology Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Immuno-Oncology Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Immuno-Oncology Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Immuno-Oncology Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Immuno-Oncology Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Immuno-Oncology Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Immuno-Oncology Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Immuno-Oncology Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Immuno-Oncology Market Size by Country (2023-2028) & (US$ Million)
Table 64. Bristol-Myers Squibb Company Details
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Immuno-Oncology Product
Table 67. Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. Merck & Co., Inc. Company Details
Table 70. Merck & Co., Inc. Business Overview
Table 71. Merck & Co., Inc. Immuno-Oncology Product
Table 72. Merck & Co., Inc. Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
Table 73. Merck & Co., Inc. Recent Developments
Table 74. Roche AG Company Details
Table 75. Roche AG Business Overview
Table 76. Roche AG Immuno-Oncology Product
Table 77. Roche AG Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
Table 78. Roche AG Recent Developments
Table 79. AstraZeneca, Plc Company Details
Table 80. AstraZeneca, Plc Business Overview
Table 81. AstraZeneca, Plc Immuno-Oncology Product
Table 82. AstraZeneca, Plc Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
Table 83. AstraZeneca, Plc Recent Developments
Table 84. Sanofi S.A. Company Details
Table 85. Sanofi S.A. Business Overview
Table 86. Sanofi S.A. Immuno-Oncology Product
Table 87. Sanofi S.A. Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
Table 88. Sanofi S.A. Recent Developments
Table 89. Dendreon Pharmaceuticals Company Details
Table 90. Dendreon Pharmaceuticals Business Overview
Table 91. Dendreon Pharmaceuticals Immuno-Oncology Product
Table 92. Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
Table 93. Dendreon Pharmaceuticals Recent Developments
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Immuno-Oncology Product
Table 97. Novartis Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
Table 98. Novartis Recent Developments
Table 99. Gilead Sciences Inc. Company Details
Table 100. Gilead Sciences Inc. Business Overview
Table 101. Gilead Sciences Inc. Immuno-Oncology Product
Table 102. Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
Table 103. Gilead Sciences Inc. Recent Developments
Table 104. Merck KGaA Company Details
Table 105. Merck KGaA Business Overview
Table 106. Merck KGaA Immuno-Oncology Product
Table 107. Merck KGaA Revenue in Immuno-Oncology Business (2017-2022) & (US$ Million)
Table 108. Merck KGaA Recent Developments
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Oncology Market Share by Type: 2021 VS 2028
Figure 2. Immune Checkpoint Inhibitors Features
Figure 3. Cytokine-Based Immunotherapy Features
Figure 4. Cancer Vaccines Features
Figure 5. CAR-T Cell Therapy Features
Figure 6. Others Features
Figure 7. Global Immuno-Oncology Market Share by Application: 2021 VS 2028
Figure 8. Hospitals Case Studies
Figure 9. Drugstores Case Studies
Figure 10. Others Case Studies
Figure 11. Immuno-Oncology Report Years Considered
Figure 12. Global Immuno-Oncology Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Immuno-Oncology Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Immuno-Oncology Market Share by Region: 2021 VS 2028
Figure 15. Global Immuno-Oncology Market Share by Players in 2021
Figure 16. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Immuno-Oncology Revenue in 2021
Figure 18. North America Immuno-Oncology Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Immuno-Oncology Market Size Market Share by Type (2017-2028)
Figure 20. North America Immuno-Oncology Market Size Market Share by Application (2017-2028)
Figure 21. North America Immuno-Oncology Market Size Share by Country (2017-2028)
Figure 22. United States Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Immuno-Oncology Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Immuno-Oncology Market Size Market Share by Type (2017-2028)
Figure 26. Europe Immuno-Oncology Market Size Market Share by Application (2017-2028)
Figure 27. Europe Immuno-Oncology Market Size Share by Country (2017-2028)
Figure 28. Germany Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Immuno-Oncology Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Immuno-Oncology Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Immuno-Oncology Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Immuno-Oncology Market Size Share by Region (2017-2028)
Figure 38. China Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Immuno-Oncology Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Immuno-Oncology Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Immuno-Oncology Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Immuno-Oncology Market Size Share by Country (2017-2028)
Figure 48. Mexico Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Immuno-Oncology Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Immuno-Oncology Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Immuno-Oncology Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Immuno-Oncology Market Size Share by Country (2017-2028)
Figure 54. Turkey Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Immuno-Oncology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
Figure 58. Merck & Co., Inc. Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
Figure 59. Roche AG Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
Figure 60. AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
Figure 61. Sanofi S.A. Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
Figure 62. Dendreon Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
Figure 63. Novartis Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
Figure 64. Gilead Sciences Inc. Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
Figure 65. Merck KGaA Revenue Growth Rate in Immuno-Oncology Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
